Nuvalent, Inc. 4 SEC Filings | Understand Stock

Filed On	Filing
17 Jul 2026	Form 4: Flynn James E, Director and 7 others Returned 17,248,450 shares to the issuer ($2.14B) · Disposed of 10,292 shares (Tender Offer) ($1.28M) · Returned 3,444 shares to the issuer ($427K) · 2 more
15 Jul 2026	Form 4: Meyers Michael L., Director Disposed of 5,146 shares (Tender Offer) ($638K) · Returned 3,444 shares to the issuer · Disposed of 71,297 Stock Option (Right to Buy) (Disposition to Issuer)
15 Jul 2026	Form 4: Balcom Alexandra, Chief Financial Officer Disposed of 44,433 shares (Tender Offer) ($5.51M) · Returned 41,100 shares to the issuer · Received 14,350 shares as a grant or award · 2 more
15 Jul 2026	Form 4: Srivastava Sapna, Director Disposed of 5,146 shares (Tender Offer) ($638K) · Returned 3,444 shares to the issuer · Disposed of 111,436 Stock Option (Right to Buy) (Disposition to Issuer)
15 Jul 2026	Form 4: Oliger Christy J., Director Disposed of 1,324 shares (Tender Offer) ($164K) · Returned 6,091 shares to the issuer · Disposed of 6,119 Stock Option (Right to Buy) (Disposition to Issuer)
15 Jul 2026	Form 4: Squarer Ron, Director Returned 6,281 shares to the issuer · Disposed of 4,418 Stock Option (Right to Buy) (Disposition to Issuer)
15 Jul 2026	Form 4: Turner Christopher Durant, Chief Medical Officer Disposed of 31,530 shares (Tender Offer) ($3.91M) · Returned 41,100 shares to the issuer · Received 14,350 shares as a grant or award · 2 more
15 Jul 2026	Form 4: Noci Darlene, Chief Development Officer Disposed of 17,017 shares (Tender Offer) ($2.11M) · Returned 41,100 shares to the issuer · Received 14,350 shares as a grant or award · 2 more
15 Jul 2026	Form 4: Lane Benjamin, See Remarks Disposed of 21,092 shares (Tender Offer) ($2.62M) · Returned 29,433 shares to the issuer · Received 7,120 shares as a grant or award · 2 more
15 Jul 2026	Form 4: Pelish Henry E., Chief Scientific Officer Disposed of 22,393 shares (Tender Offer) ($2.78M) · Returned 41,100 shares to the issuer · Received 14,350 shares as a grant or award · 2 more
15 Jul 2026	Form 4: Porter James Richard, Director Disposed of 203,529 shares (Tender Offer) ($25.2M) · Returned 121,350 shares to the issuer · Received 40,025 shares as a grant or award · 2 more
15 Jul 2026	Form 4: Miller Deborah Ann, Chief Legal Officer Disposed of 18,534 shares (Tender Offer) ($2.3M) · Returned 41,100 shares to the issuer · Received 14,350 shares as a grant or award · 2 more
15 Jul 2026	Form 4: Protopapas Anna, Director Disposed of 5,146 shares (Tender Offer) ($638K) · Returned 3,444 shares to the issuer · Disposed of 77,936 Stock Option (Right to Buy) (Disposition to Issuer)
15 Jul 2026	Form 4: Bogle Grant C., Director Disposed of 3,714 shares (Tender Offer) ($461K) · Returned 5,577 shares to the issuer · Disposed of 8,998 Stock Option (Right to Buy) (Disposition to Issuer)
15 Jul 2026	Form 4: Wheeler Cameron, Director Disposed of 5,146 shares (Tender Offer) ($638K) · Returned 3,444 shares to the issuer · Disposed of 85,936 Stock Option (Right to Buy) (Disposition to Issuer)
10 Jul 2026	Form 4: Pelish Henry E., Chief Scientific Officer Sold 2,111 shares ($261K)
08 Jul 2026	Form 4: Porter James Richard, Director Received 30,000 shares by exercise or conversion ($568K) · Sold 30,000 shares ($3.71M)
06 Jul 2026	Form 4: Noci Darlene, Chief Development Officer Received 23,000 shares by exercise or conversion ($1.18M) · Sold 23,000 shares ($2.84M)
06 Jul 2026	Form 4: Balcom Alexandra, Chief Financial Officer Received 11,430 shares by exercise or conversion ($152K) · Sold 11,430 shares ($1.41M)
01 Jul 2026	Form 4: Noci Darlene, Chief Development Officer Received 5,500 shares by exercise or conversion ($153K) · Sold 5,500 shares ($679K)

17 Jul 2026

Form 4: Flynn James E, Director and 7 others

Returned 17,248,450 shares to the issuer ($2.14B) · Disposed of 10,292 shares (Tender Offer) ($1.28M) · Returned 3,444 shares to the issuer ($427K) · 2 more

15 Jul 2026

Form 4: Meyers Michael L., Director

Disposed of 5,146 shares (Tender Offer) ($638K) · Returned 3,444 shares to the issuer · Disposed of 71,297 Stock Option (Right to Buy) (Disposition to Issuer)

15 Jul 2026

Form 4: Balcom Alexandra, Chief Financial Officer

Disposed of 44,433 shares (Tender Offer) ($5.51M) · Returned 41,100 shares to the issuer · Received 14,350 shares as a grant or award · 2 more

15 Jul 2026

Form 4: Srivastava Sapna, Director

Disposed of 5,146 shares (Tender Offer) ($638K) · Returned 3,444 shares to the issuer · Disposed of 111,436 Stock Option (Right to Buy) (Disposition to Issuer)

15 Jul 2026

Form 4: Oliger Christy J., Director

Disposed of 1,324 shares (Tender Offer) ($164K) · Returned 6,091 shares to the issuer · Disposed of 6,119 Stock Option (Right to Buy) (Disposition to Issuer)

15 Jul 2026

Form 4: Squarer Ron, Director

Returned 6,281 shares to the issuer · Disposed of 4,418 Stock Option (Right to Buy) (Disposition to Issuer)

15 Jul 2026

Form 4: Turner Christopher Durant, Chief Medical Officer

Disposed of 31,530 shares (Tender Offer) ($3.91M) · Returned 41,100 shares to the issuer · Received 14,350 shares as a grant or award · 2 more

15 Jul 2026

Form 4: Noci Darlene, Chief Development Officer

Disposed of 17,017 shares (Tender Offer) ($2.11M) · Returned 41,100 shares to the issuer · Received 14,350 shares as a grant or award · 2 more

15 Jul 2026

Form 4: Lane Benjamin, See Remarks

Disposed of 21,092 shares (Tender Offer) ($2.62M) · Returned 29,433 shares to the issuer · Received 7,120 shares as a grant or award · 2 more

15 Jul 2026

Form 4: Pelish Henry E., Chief Scientific Officer

Disposed of 22,393 shares (Tender Offer) ($2.78M) · Returned 41,100 shares to the issuer · Received 14,350 shares as a grant or award · 2 more

15 Jul 2026

Form 4: Porter James Richard, Director

Disposed of 203,529 shares (Tender Offer) ($25.2M) · Returned 121,350 shares to the issuer · Received 40,025 shares as a grant or award · 2 more

15 Jul 2026

Form 4: Miller Deborah Ann, Chief Legal Officer

Disposed of 18,534 shares (Tender Offer) ($2.3M) · Returned 41,100 shares to the issuer · Received 14,350 shares as a grant or award · 2 more

15 Jul 2026

Form 4: Protopapas Anna, Director

Disposed of 5,146 shares (Tender Offer) ($638K) · Returned 3,444 shares to the issuer · Disposed of 77,936 Stock Option (Right to Buy) (Disposition to Issuer)

15 Jul 2026

Form 4: Bogle Grant C., Director

Disposed of 3,714 shares (Tender Offer) ($461K) · Returned 5,577 shares to the issuer · Disposed of 8,998 Stock Option (Right to Buy) (Disposition to Issuer)

15 Jul 2026

Form 4: Wheeler Cameron, Director

Disposed of 5,146 shares (Tender Offer) ($638K) · Returned 3,444 shares to the issuer · Disposed of 85,936 Stock Option (Right to Buy) (Disposition to Issuer)

10 Jul 2026

Form 4: Pelish Henry E., Chief Scientific Officer

Sold 2,111 shares ($261K)

08 Jul 2026

Form 4: Porter James Richard, Director

Received 30,000 shares by exercise or conversion ($568K) · Sold 30,000 shares ($3.71M)

06 Jul 2026

Form 4: Noci Darlene, Chief Development Officer

Received 23,000 shares by exercise or conversion ($1.18M) · Sold 23,000 shares ($2.84M)

06 Jul 2026

Form 4: Balcom Alexandra, Chief Financial Officer

Received 11,430 shares by exercise or conversion ($152K) · Sold 11,430 shares ($1.41M)

01 Jul 2026

Form 4: Noci Darlene, Chief Development Officer

Received 5,500 shares by exercise or conversion ($153K) · Sold 5,500 shares ($679K)